EFFICACY AND SAFETY OF IGLARLIXI IN HISPANICS AND NON-HISPANIC WHITES WITH TYPE 2 DIABETES

Pablo F. Mora,Jason Chao,Aramesh Saremi,Terry Dex,Michelle Roberts,Guillermo E. Umpierrez

EFFICACY AND SAFETY OF IGLARLIXI IN HISPANICS AND NON-HISPANIC WHITES WITH TYPE 2 DIABETES

2019

Pablo F. Mora
Jason Chao
Aramesh Saremi
Terry Dex
Michelle Roberts
Guillermo E. Umpierrez

ABSTRACT Objective: Type 2 diabetes (T2D) is more common in Hispanic than non-Hispanic white (NHW) populations worldwide, and ethnicity, among other factors, may affect response to therapy. The eff...

Keywords:

Diabetes mellitus
Demography
Ethnic group
Internal medicine
Medicine
Endocrinology
Non-Hispanic whites
Type 2 diabetes
response to therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations